Aethlon Medical (AEMD) News Today $1.20 +0.02 (+1.26%) As of 10:09 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock AEMD Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Aethlon Medical (NASDAQ:AEMD) Coverage Initiated by Analysts at HC WainwrightJuly 8 at 3:25 AM | americanbankingnews.comFinancial Analysis: Aethlon Medical (NASDAQ:AEMD) versus Cigna Group (NYSE:CI)July 8 at 2:46 AM | americanbankingnews.comCritical Contrast: Cigna Group (NYSE:CI) & Aethlon Medical (NASDAQ:AEMD)July 7 at 2:07 AM | americanbankingnews.comAEMD - Aethlon Medical Inc Ownership - MorningstarJuly 5, 2025 | morningstar.comMZacks Small Cap Predicts Aethlon Medical Q1 EarningsJuly 5, 2025 | americanbankingnews.comAethlon’s Earnings Call: Clinical Progress Amid Financial HurdlesJuly 4, 2025 | theglobeandmail.comAEMD: Progressing & Expanding Clinical & Pre-Clinical Activities in Cost Efficient MannerJuly 2, 2025 | finance.yahoo.comAethlon Medical Inc (AEMD) Share Chat - Investing.com UKJune 29, 2025 | uk.investing.comAethlon Medical Reports Progress in Cancer TrialsJune 26, 2025 | tipranks.comAethlon Medical, Inc. (AEMD) Q4 2025 Earnings Call TranscriptJune 26, 2025 | seekingalpha.comEarnings Scheduled For June 26, 2025June 26, 2025 | benzinga.comAethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate UpdateJune 26, 2025 | prnewswire.comAethlon Medical, Inc. (AEMD) - Yahoo FinanceJune 26, 2025 | finance.yahoo.comAEMD Aethlon Medical, Inc. - Seeking AlphaJune 25, 2025 | seekingalpha.comAethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025June 20, 2025 | prnewswire.comAethlon Medical at Emerging Growth Conference 83: Strategic Updates on HemopurifierJune 19, 2025 | investing.comAethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer TrialJune 18, 2025 | prnewswire.comAEMD: Virtual Meeting With Management, Upcoming Presentation of Data in Long CovidJune 12, 2025 | finance.yahoo.comAethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection SyndromesJune 9, 2025 | prnewswire.comAethlon Medical Approves Reverse Stock Split PlanJune 5, 2025 | tipranks.comAethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from PlasmaMay 14, 2025 | prnewswire.comAethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology JournalMarch 10, 2025 | prnewswire.comAethlon Medical (AEMD) Receives a Hold from Maxim GroupFebruary 14, 2025 | markets.businessinsider.comAEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating Site, Protocol AmendmentsFebruary 13, 2025 | finance.yahoo.comAEMD: Patient Enrollments in Oncology Trial Expected to Accelerate With 3rd Participating Site, Protocol AmendmentsFebruary 13, 2025 | finance.yahoo.comAethlon Medical, Inc. (NASDAQ:AEMD) Q3 2025 Earnings Call TranscriptFebruary 13, 2025 | msn.comAethlon Medical to Present at the Emerging Growth Conference on February 19, 2025February 13, 2025 | prnewswire.comAethlon Medical strengthens oncology trial with protocol updates and cost reductionsFebruary 12, 2025 | msn.comAethlon Medical, Inc. (AEMD) Q3 2025 Earnings Call TranscriptFebruary 12, 2025 | seekingalpha.comAethlon Medical reports Q3 EPS (13c), consensus (20c)February 12, 2025 | markets.businessinsider.comAethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate UpdateFebruary 12, 2025 | prnewswire.comAethlon Medical Q3 2025 Earnings PreviewFebruary 12, 2025 | msn.comAethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025February 5, 2025 | prnewswire.comAethlon Medical treats first subject with Hemopurifier device in AustraliaJanuary 30, 2025 | msn.comAEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of HemopurifierJanuary 30, 2025 | msn.comAethlon Medical Treats First Patient in Australian Hemopurifier® Cancer TrialJanuary 29, 2025 | prnewswire.comAethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird FluDecember 20, 2024 | prnewswire.comAethlon’s Future at Risk: Financial Struggles, Stockholder Dilution, and Market Challenges LoomNovember 15, 2024 | markets.businessinsider.comMaxim Group Sticks to Their Hold Rating for Aethlon Medical (AEMD)November 15, 2024 | markets.businessinsider.comAethlon Medical, Inc. (NASDAQ:AEMD) Q2 2025 Earnings Call TranscriptNovember 15, 2024 | msn.comAethlon Medical Advances Oncology Trials and Global ExpansionNovember 15, 2024 | markets.businessinsider.comAEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost Containment MeasuresNovember 15, 2024 | msn.comAethlon Medical Reports Progress in Oncology TrialsNovember 14, 2024 | markets.businessinsider.comAethlon Medical, Inc. (AEMD) Q2 2025 Earnings Call TranscriptNovember 13, 2024 | seekingalpha.comAethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate UpdateNovember 13, 2024 | prnewswire.comAethlon Medical enrolls first patient in Hemopurifier cancer trial in AustraliaNovember 12, 2024 | markets.businessinsider.comAn Overview of Aethlon Medical's EarningsNovember 12, 2024 | benzinga.comAethlon Medical, Inc.: Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier Cancer Trial in AustraliaNovember 11, 2024 | finanznachrichten.deAethlon Medical enrols first patient in trial of Hemopurifier device for cancerNovember 11, 2024 | msn.comAethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in AustraliaNovember 11, 2024 | prnewswire.com Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Email Address AEMD Media Mentions By Week AEMD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AEMD News Sentiment▼0.810.57▲Average Medical News Sentiment AEMD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AEMD Articles This Week▼111▲AEMD Articles Average Week Get Aethlon Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AEMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies LYRA News DHAI News IINN News INBS News WOK News PAVM News BTCY News SSKN News NURO News CODX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AEMD) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aethlon Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aethlon Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
